The inaugural post at the Personalized Medicine Coalition's new blog discusses the interplay of personalized medicine and comparative effectiveness. Amy Miller at The Age of Personalized Medicine writes that if "done right, CER could do more to advance personalized medicine than any other policy under consideration right now" but if "done wrong" could set the field back.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.